Watch INBS. Know when insiders buy.
One email the day a filing lands. Free.
INBS
INTELLIGENT BIO SOLUTIONS INC.
2.00
+0.03 +1.52%
USD · close Sep 17
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.1MP/E —DIV YIELD —FCF YIELD -199.06%REV TTM $4.2M +38.1%NET INCOME −$12.4MNET CASH $2.3M52W 1.55 – 17.92SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2026 · Jun 30derived | $1.1M | +178.9% | 46.8% | −$4M | −$3.9M | — | -0.90 | −$3.2M | $0 | −$3.2M | Aug 19 |
| Q3 2026 · Mar 31 | $1.1M | +17.6% | 50.5% | −$2.9M | −$2.9M | — | -1.80 | −$4.3M | −$13K | −$4.3M | May 13 |
| Q2 2026 · Dec 31 | $897K | +21.0% | 51.3% | −$2.6M | −$2.7M | — | -2.82 | −$1.6M | $68K | −$1.6M | Feb 12 |
| Q1 2026 · Sep 30 | $1.1M | +11.4% | 46.6% | −$3M | −$3M | — | -0.35 | −$2.8M | $70K | −$2.9M | Nov 12 |
| Q4 2025 · Jun 30derived | $411K | +7.9% | 81.7% | −$3.1M | −$3.1M | — | -4.12 | −$2.2M | — | — | Aug 19 |
| Q3 2025 · Mar 31 | $902K | −0.6% | 37.8% | −$2.6M | −$2.5M | — | -4.41 | −$2.8M | — | — | May 13 |
| Q2 2025 · Dec 31 | $741K | −19.2% | 30.1% | −$2.3M | −$2.2M | — | -4.96 | −$2.3M | — | — | Feb 12 |
| Q1 2025 · Sep 30 | $998K | +10.2% | 34.7% | −$2.7M | −$2.7M | — | -0.70 | −$2.4M | — | — | Nov 12 |
| Q4 2024 · Jun 30derived | $381K | — | 214.1% | −$2.8M | −$2.8M | — | 0.26 | −$2.9M | — | — | Aug 15 |
| Q3 2024 · Mar 31 | $908K | — | 19.7% | −$3M | −$3M | — | -1.43 | −$2.4M | — | — | May 13 |
| Q2 2024 · Dec 31 | $917K | — | 21.7% | −$2M | −$2M | — | -2.07 | −$2.9M | — | — | Feb 13 |
| Q1 2024 · Sep 30 | $906K | — | 25.6% | −$2.5M | −$2.4M | — | -12.48 | −$1.3M | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jun 30 | $4.2M | 48.6% | −$12.6M | −$12.4M | -294.9% | -8.44 | −$11.9M | $126K | −$12.1M | — | — |
| FY2025 · to Jun 30 | $3.1M | 40.8% | −$10.7M | −$10.6M | -346.2% | -20.04 | −$9.7M | $232K | −$9.9M | — | — |
| FY2024 · to Jun 30 | $3.1M | 45.8% | −$10.3M | −$10.2M | -326.4% | -6.38 | −$9.6M | $221K | −$9.8M | — | — |
| FY2023 · to Jun 30 | $1.3M | 26.0% | −$12.6M | −$10.6M | -845.9% | -127.00 | −$7.4M | — | — | — | — |
| FY2022 · to Jun 30 | $437K | — | −$8.3M | −$8.3M | -1900.1% | -11.33 | −$3.4M | — | — | — | — |
| FY2021 · to Jun 30 | $2M | — | −$5.6M | −$7M | -355.3% | -0.68 | −$11.3M | — | — | — | — |
Every number comes from INTELLIGENT BIO SOLUTIONS INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.